MINNEAPOLIS--(BUSINESS WIRE)--Germany-based Kalms Consulting GmbH, headed by medical device veteran Marco Kalms, has established offices in two of the most vital health technology clusters in the world: Minneapolis, MN and San Francisco, CA.
Navigating FDA approval can be a significant investment in time and dollars. Executing a dual pathway strategy via the European market can provide a streamlined opportunity that quickly allows manufacturers to jumpstart revenue gains, develop a strong health economics story, and aggregate additional clinical data needed to successfully execute approval in the U.S. The European market is also an attractive target for well-established companies looking to expand beyond their native country.
Kalms Consulting enjoys longstanding relationships with small, mid-cap and large, US-based medical device, biotech, biopharma and life science clients who continue to benefit from broadening their revenue pathways in Europe. Establishing offices in the United States to better serve existing and future clients made perfect sense. The Kalms Consulting team is comprised of well-tenured and highly qualified experts who deliver affordable, data-driven solutions to clients worldwide. The U.S. division will specifically focus its efforts on market access, strategic business development, technology assessment and market analysis while working in concert with their European counterparts.
The organization’s objective is to help clients navigate, establish and execute sound market access strategies originating in Germany; which serves as the gateway for other European countries. Kalms Consulting’s unique modular approach combines market access analytics with the ability to manage all operational activities, including market development, logistics, warehousing and distribution. “We are expanding our global footprint to make it more efficient for our clients to expand theirs,” explains founder and CEO, Marco Kalms.
Kalms Consulting portfolio of services:
| -- Market Access Strategies | -- Valuation Models | ||
| -- Market Development | -- Exit Strategy | ||
| -- Data Driven Analytics | -- Public Affairs/Public Relations | ||
| -- Reimbursement Codes and Modeling | -- Health Economics | ||
| -- Pricing Structures | -- Logistics, Warehousing & Distribution | ||
“Establishing offices in Minneapolis and San Francisco put us squarely in the heart of US health innovation,” comments Mr. Kalms. “Bringing robust strategies to these ecosystems helps keep organizations on a productive commercialization path that will establish early or additional sources of revenue and long-term market security.” Learn more about Kalms Consulting: www.kalmsconsult.com.
About Kalms Consulting
Berlin-based Kalms Consulting offers
affordable, turnkey market access consultancy services for medical
device manufacturers and biopharmaceutical companies. A highly-qualified
team with robust European experience and expertise, from market access
to reimbursement to distribution, makes Kalms Consulting a natural
partner for every size organization looking to expand its revenue
opportunities outside the United States. Germany is a stable, prosperous
environment with a thriving health care system and rigorous CE Mark
approval processes. The German market serves as a European benchmark and
an ideal gateway for all other European market considerations; which
makes subsequent market approvals more likely to follow. For more
information, visit: www.kalmsconsult.com.
